So the Paramount-Skydance merger isn’t necessarily proceeding more slowly, but it is playing out in an unusual way, with two separate issues emerging as sticking points: Paramount’s diversity ...

For the first time since 1998, the U.S. Food and Drug Administration is expected to review the nutrients and other ingredients in formula.